CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 1 Drug-Drug Interaction Study of the Effects of XL184 on the Pharmacokinetics of a Single Oral Dose of Rosiglitazone in Subjects With Solid Tumors

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01100619
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:35:26.519583+00:00
Published At: 2013-09-19T00:00:00+00:00
Record Updated At: 2013-09-19
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Papillary Thyroid Cancer", "Follicular Thyroid Cancer", "Huerthle Cell Thyroid Cancer", "Renal Cell Carcinoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2013-09-19"
protocolSection.identificationModule.nctId: "NCT01100619"
protocolSection.identificationModule.officialTitle: "A Phase 1 Drug-Drug Interaction Study of the Effects of XL184 on the Pharmacokinetics of a Single Oral Dose of Rosiglitazone in Subjects With Solid Tumors"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.